Yusi Anggriani
Biographic Data
| ID | 9073139 |
|---|---|
| NAME | Yusi Anggriani |
| GIVEN NAMES | Yusi |
| FAMILY NAME | Anggriani |
| SIGNATURE | ANGGRIANI Y |
| AFFILIATIONS | Pancasila University |
| ORCID | 0000-0001-7787-0539 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Are quality medicines affordable? Evidence from a large survey of medicine price and quality in Indonesia
BACKGROUND: Since Indonesia implemented one of the world's largest single-payer health insurance schemes in 2014, the price of many common medicines has fallen dramatically. Industry groups warn unsustainably low prices threaten quality, while the government says medicines remain overpriced. We investigate the relationship between the price and quality of essential medicines and the affordability of medicines paid for out of pocket. METHODS: We b…
Value for money of medicine sampling and quality testing
BACKGROUND: Substandard and falsified medicines (SFMs) are a public health concern of global importance. Postmarket surveillance in the form of medicine sampling and quality testing can prevent and detect SFM, however, there is remarkably scarce evidence about the cost and value for money of these activities: how much do they cost and how effective are they in detecting SFM? METHODS: Between February and October 2022, Systematic Tracking of At Ri…
A randomised survey of the quality of antibiotics and other essential medicines in Indonesia, with volume-adjusted estimates of the prevalence of substandard medicines
The World Health Organization warns that substandard and falsified medicines threaten public health in low- and middle-income countries. However, medicine quality surveys are often small and unrepresentative of the market, and the true scale of the problem remains unknown. We conducted a large field survey of essential medicines in Indonesia, and investigated how weighting survey results by market volume altered estimates of medicine quality. We …
No prominent works on this page.
Value for money of medicine sampling and quality testing
BACKGROUND: Substandard and falsified medicines (SFMs) are a public health concern of global importance. Postmarket surveillance in the form of medicine sampling and quality testing can prevent and detect SFM, however, there is remarkably scarce evidence about the cost and value for money of these activities: how much do they cost and how effective are they in detecting SFM? METHODS: Between February and October 2022, Systematic Tracking of At Ri…
A randomised survey of the quality of antibiotics and other essential medicines in Indonesia, with volume-adjusted estimates of the prevalence of substandard medicines
The World Health Organization warns that substandard and falsified medicines threaten public health in low- and middle-income countries. However, medicine quality surveys are often small and unrepresentative of the market, and the true scale of the problem remains unknown. We conducted a large field survey of essential medicines in Indonesia, and investigated how weighting survey results by market volume altered estimates of medicine quality. We …
Are quality medicines affordable? Evidence from a large survey of medicine price and quality in Indonesia
BACKGROUND: Since Indonesia implemented one of the world's largest single-payer health insurance schemes in 2014, the price of many common medicines has fallen dramatically. Industry groups warn unsustainably low prices threaten quality, while the government says medicines remain overpriced. We investigate the relationship between the price and quality of essential medicines and the affordability of medicines paid for out of pocket. METHODS: We b…
Medicine (3 works) · Pharmaceutical Economics and Policy (3 works) · Pharmaceutical Quality and Counterfeiting (3 works) · Biosimilars and Bioanalytical Methods (1 work) · Business (1 work) · Computer Science (1 work) · Economic and Financial Impacts of Cancer (1 work) · Economics (1 work) · Environmental health (1 work) · Family medicine (1 work)